Quantcast

Latest Wyeth Stories

2014-10-22 08:32:01

Architect of Novel Translational Rare Disease Programs at NIH Adds Depth to Existing Team of Rare Disease Experts SAN DIEGO and HONG KONG, Oct. 22, 2014 /PRNewswire/ -- aTyr Pharma ("aTyr"), an innovative rare disease therapeutics enterprise, announced today that rare disease expert John C. McKew, Ph.D., joined the company as vice president, research. Dr. McKew brings more than two decades of expertise in translational research, including key leadership positions at the National...

2014-09-23 08:29:51

PRINCETON, N.J., Sept. 23, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has appointed Rasappa Arumugham, PhD, as its Vice President of Biopharmaceutical Development. Dr. Arumugham has over 25 years of diverse experience in biopharmaceutical research and development (R&D) in the...

2014-08-19 16:29:38

Alabama Supreme Court decision is an important win for patients in cases involving prescription drugs BIRMINGHAM, Ala., Aug. 19, 2014 /PRNewswire/ -- The Alabama Supreme Court, in a 6-3 decision on August 15, 2014, re-affirmed that patients can sue drug makers who mislead doctors into believing that prescription medicines the companies market do not cause harmful side?effects. The case is Weeks v. Wyeth, and the decision came after the Supreme Court ruled against the drug makers in...

2014-07-21 08:30:52

LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Antibody Drug Conjugate Market Outlook 2018https://www.reportbuyer.com/product/2048454/Global-Antibody-Drug-Conjugate-Market-Outlook-2018.html The ADC technology is not new. It dates back to the 90s. However, several issues such as specificity of the payload (drug), and poor conjugation of drug and antibody proved a setback. But, the past few years have witnessed ADCs make a glorious...

2014-07-16 08:28:14

Company Advances Development as Part of Collaboration with Baxter International's Biopharmaceutical Business REDWOOD CITY, Calif., July 16, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, a proposed biosimilar of etanercept (Enbrel®), in chronic plaque psoriasis (the RaPsOdy trial). This announcement follows the recent initiation of a Phase 3 trial of CHS-0214 in rheumatoid arthritis. The Phase 3 psoriasis trial is a 48-week,...

2014-07-15 16:27:44

LONDON, July 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023https://www.reportbuyer.com/product/2166742/Pristiq-Major-Depressive-Disorder---Forecast-and-Market-Analysis-to-2023.htmlPristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023SummaryMajor depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded...

2014-06-04 08:27:22

Seminar Unlocks Secrets of Persons' Names SAN ANTONIO, June 4, 2014 /PRNewswire/ -- Forget those complicated and expensive personality tests and assessments. If you really want to know what's in a person's mind, look no further than their name. http://photos.prnewswire.com/prnvar/20140603/94035 "Each of us has a wonderful guidance system that is built into our birth name," said Sharon Lynn Wyeth, founder of Neimology® Science, which is the study of the placement of letters in a name, and how...

2014-05-12 23:09:29

Wright & Schulte LLC Files Effexor Lawsuit on Behalf of an Ohio Woman Who’s Child Was Born with Birth Defects Allegedly Due to the Antidepressant Drug Effexor Columbus, OH (PRWEB) May 12, 2014 An Effexor lawsuit was filed by Wright & Schulte LLC on behalf of an Ohio woman whose child was born with birth defects allegedly because she took the SSRI antidepressant drug Effexor while she was pregnan t. This Effexor lawsuit was filed in the U.S. District Court, Northern District of...

2014-04-23 12:29:37

New Entity YL Biologics to focus on clinical development and commercialization of Biosimilars for Japan MUMBAI and BALTIMORE, April 23, 2014 /PRNewswire/ -- Pharma Major, Lupin Limited (Lupin) announced today that it has entered into a strategic joint venture agreement with Toyama based Japanese pharmaceuticals company, Yoshindo Inc. (Yoshindo) to create a new entity, YL Biologics (YLB). YLB will be jointly managed by both partners and will be responsible for conducting...

2014-04-08 16:22:55

Exec to Support Life Science Research Clients in Booming Southwestern Market SALT LAKE CITY, April 8, 2014 /PRNewswire/ -- Numira, a leader in high resolution, 3D imaging services, visualization software, and cloud computing for the life science market, today announced the appointment of Kim Killian as Regional Sales Manager of the Southwestern region. "As we've seen remarkable growth opportunities in the western United States, we knew we needed to bring on new and exceptional...


Latest Wyeth Reference Libraries

2012-06-15 04:47:18

Symbol: LUWY Group: Dicot Family: Fabaceae Duration: Perennial Growth Habit: Forb/herb Native Status: L48    N CAN    N Distribution: County distributions for the following U.S. states are available at PLANTS:ID, MT, UT, WA, WY Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Superdivision   Spermatophyta – Seed plants Division   Magnoliophyta –...

2012-06-15 04:47:18

Symbol: LUWYW Group: Dicot Family: Fabaceae Duration: Perennial Growth Habit: Forb/herb Native Status: L48    N CAN    N Synonyms:   LUARH2 Lupinus arcticus S. Watson var. humicola (A. Nelson) C.P. Sm.   LUCA12 Lupinus candicans Rydb.   LUDI4 Lupinus diversalpicola C.P. Sm.   LUFL6 Lupinus flavescens Rydb.   LUHU2 Lupinus humicola A. Nelson   LUPOH Lupinus polyphyllus Lindl. var. humicola (A. Nelson) Barneby  ...

More Articles (2 articles) »
Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related